MK-8666
Total Payments
$17,049
Transactions
1
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $17,049 | 1 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $17,049 | 1 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of MK-8666 in Healthy Japanese Subjects | Merck Sharp & Dohme Corporation | $17,049 | 0 |
Top Doctors Receiving Payments for MK-8666
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Waltham, MA | $17,049 | 1 |
Ad
Manufacturing Companies
- Merck Sharp & Dohme Corporation $17,049
Product Information
- Type Drug
- Total Payments $17,049
- Total Doctors 0
- Transactions 1
About MK-8666
MK-8666 is a drug associated with $17,049 in payments to 0 healthcare providers, recorded across 1 transactions in the CMS Open Payments database. The primary manufacturer is Merck Sharp & Dohme Corporation.
Payment data is available from 2017 to 2017. In 2017, $17,049 was paid across 1 transactions to 0 doctors.
The most common payment nature for MK-8666 is "Unspecified" ($17,049, 100.0% of total).
MK-8666 is associated with 1 research study, including "A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of MK-8666 in Healthy Japanese Subjects" ($17,049).